News Center

March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding...

By Daryl Spinner, PhD, MBA In the realm of genetic testing, insurance payers have been reluctant to recognize that there...

When solving a problem, taking a step back and looking at the big picture is often a wise tactic. In...

Given that genome sequencing has the potential to identify tens of thousands of variants in every patient sample tested, our...

January 26, 2021 Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity®...

By Toni Lewis The use of whole-genome sequencing (WGS) in diagnostic testing brings up the topic of secondary findings or...

January 12, 2021 Clinicians at Variantyx, a leader in high complexity hereditary disease testing, recently completed analysis of their 2,500th...

In 2003, an international consortium of health institutes and government agencies completed “The Human Genome Project.” The significance of the...

It’s well known that FXN variants cause Friedreich’s ataxia – a progressive form of ataxia that usually affects individuals before 25 years...

In short, yes! But let’s take a step back and start with what mitochondrial disease is. We have to start...